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zation, food allergy and a maximum of complaints in Sep-
tember or October. County of residence, extent of local rag-
weed cover or type of residential area were without rele-
vance. Of 48 sensitized patients, 26 (54.2%) had a positive 
conjunctival provocation test.  Discussion: Patients with 
multiple sensitizations may be more readily sensitized to a 
new aeroallergen. Local geographic or environmental con-
ditions are presumably of minor importance for becoming 
sensitized to ragweed. The frequency of ragweed allergy 
among sensitized patients might be high. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 There has been an increase in the prevalence of allergic 
rhinitis in many countries over the last two decades, es-
pecially in industrialized countries  [1] . In the context of 
global warming, it is foreseen that the longer duration of 
the growing season will probably enhance higher pollen 
concentration stimulated by the rise of atmospheric CO 2 
 [2] . The types of pollen responsible for symptoms vary 
widely with locale, climate and regional plantings  [3] . In 
North America, common ragweed  (Ambrosia artemi-
siifolia) is the prime cause of allergic rhinitis. One single 
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 Abstract 
 Background: Sensitization to common ragweed  (Ambrosia 
artemisiifolia) is associated with a variety of risk factors, 
which are incompletely defined. Our aim was to evaluate the 
association of a variety of clinical, geographical and demo-
graphical variables with ragweed sensitization and also to 
determine its frequency in southern Bavaria.  Methods: In 
this cross-sectional multicentre study, we enrolled 977 pa-
tients with a documented or suspected atopic disease or 
food allergy. Data were collected on aeroallergen sensitiza-
tion, age, sex, type and history of allergic disease, place of 
residence and potential local ragweed exposure. For this last 
variable, county ragweed cover was taken as a surrogate 
variable. Relative rates were calculated with multiple addi-
tive logistic regression models. Randomly selected patients 
with ragweed sensitization had a conjunctival provocation 
test.  Results: According to skin prick tests, 190 patients 
(19.5%) were sensitized to ragweed. The frequency of this 
finding increased significantly with a rising number of addi-
tional sensitizations. Other less important predictors for a 
ragweed sensitization were male gender, mugwort sensiti-
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plant alone may produce millions of ragweed pollen 
grains. Since the pollen grains are small (18–22   m) they 
are often involved in episodes of long-distance transport 
 [4] . Very low concentrations such as 5–10 pollen grains 
per cubic meter of air are sufficient to trigger allergic re-
actions in sensitive patients, and ragweed pollen may 
cause asthma much more frequently than other pollens 
 [5, 6] .
 Originally, ragweed did not belong to the domestic 
flora in Europe, and was probably imported already in 
the 19th century by contaminated seeds from North 
America. Initially, only Hungary experienced consider-
able spreading of  A.  artemisiifolia around the early 1990s, 
when the abandonment of large-style collective agricul-
ture resulted in large fields with concurrent ragweed in-
vasion. Before the year 2000, the spread of ragweed and 
the consecutive sensitization in other European coun-
tries were reported to be of only minor importance, with 
the highest rates registered in certain regions of France 
(Rhone valley), Croatia, northern Italy, The Netherlands 
and the UK  [7] . The spread of  A.  artemisiifolia plants in 
Germany occurred later, but was extremely fast; by 2007, 
the area infested in Germany was 10 times larger than 
that found in 2000  [8] . 
 During the last decade, German authorities became 
increasingly aware of this change, and the question arose 
as to what extent the population in southern Bavaria 
might be exposed to a new allergen, and whether this in-
creased exposure would mandate preventive measures 
such as plant eradication on a large scale. To get a pre-
liminary idea of the dimension of the problem, the Bavar-
ian State Ministry of the Environment and Public Health 
initiated this present cross-sectional study to document 
the regional frequency of ragweed sensitization in high-
risk patients. In addition, by using a random sample, we 
attempted to estimate the frequency to become allergic to 
ragweed when sensitized. A further aim of the study was 
to identify clinical determinants for ragweed sensitiza-
tion after adjusting to geographic or environmental con-
founders.
 Methods 
 Study Design 
 Initiated by the Bavarian State Ministry of the Environment 
and Public Health, this is a cross-sectional cohort study per-
formed in Bavaria (Munich and 3 smaller towns in Lower Bavar-
ia and Swabia). The primary study outcome was the documenta-
tion of a ragweed sensitization. The study was designed to permit 
the detection of a 1.4-fold difference in the prevalence of a rag-
weed sensitization between 2 equal groups. A total of about 200 
new cases of ragweed sensitization were required to give the study 
sufficient power to detect such an increase in frequency (2-sided 
type I error, 5%; power, 90%). Based on data from a neighbouring 
country (Vienna, Austria)  [9] , the frequency of ragweed sensitiza-
tion among high-risk patients was assumed to be 200 per 1,000 
patients, and hence the study had to collect at least 900 patients 
with a high risk for ragweed sensitization before the primary ob-
jective could be examined. The prospective data collection was 
approved by the Institutional Review Board of the Munich centre 
and each patient consented to participate in the study. 
 Collection of Data 
 Enrolment 
 Enrolment of patients began in October 2006 and completed 
by the beginning of 2009. Eligible were outpatients who were at 
least 18 years old and who presented with a suspected or docu-
mented, present or former atopic disease (allergic airway disease, 
atopic dermatitis) or food allergy. Diagnosis of diseases (allergic 
asthma, allergic rhinoconjunctivitis, atopic eczema and food al-
lergy) followed specific guidelines  [3, 10, 11] . In particular, food 
allergy was diagnosed if a patient presented with immediate-type 
symptoms (oral allergy syndrome and/or systemic anaphylactic 
symptoms) and simultaneously had a sensitization to the culprit 
food according to skin prick test results or demonstration of spe-
cific serum IgE. Patients were excluded if they were pregnant or 
suffering from severe comorbidities, or if they were not eligible for 
routine allergy testing because of contraindications  [10, 11] .
 Patient History 
 History was documented in a questionnaire, which included 
information about the history of a potential allergic disease, med-
ication and demographic data. We specifically recorded where the 
patient lived (by Bavarian county or by residential area, i.e. urban, 
suburban or rural). We also categorized patients according to their 
history of residential changes. Patients were divided into those 
who had never left the state of Bavaria before, those who had 
moved to Bavaria from another German state and those who had 
been living in an area with a presumably high ragweed exposure 
(e.g. North America, the former Yugoslavian states, Hungary, Po-
land, the Rhone valley, northern Italy) for more than 3 months. We 
wanted hereby to separate those patients who had just left Bavaria 
for a short time for recreational reasons from those who had been 
living abroad for a longer time for occupational or private reasons.
 In addition, patients were classified according to the extent of 
ragweed cover in the county in which they were living. To do so, 
we used information kindly provided by the German Task Force 
for Biodiversity and Landscape Ecology  [12] . County ragweed 
cover between 2006 and 2008 was described as the area (m 2 ) cov-
ered with ragweed plants. Seven different classes were possible: 0, 
1–99 m 2 , 100–999 m 2 , 1,000–4,999 m 2 , 5,000–9,999 m 2 , 10,000–
49,999 m 2 and  6 50,000 m 2 . The regional extent of ragweed cov-
er was taken as a surrogate variable for ragweed allergen expo-
sure. During the time of the study, only the former variable was 
available for evaluation in Bavaria. 
 For all patients with allergic airway symptoms, we recorded in 
detail: in which year symptoms had been noticed for the first time, 
during how many months of the year symptoms were present and 
in which months they reached their maximum. We also recorded 
gender, age and any anti-allergic medication due to allergic symp-
toms.
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 Data Accuracy 
 Accuracy of data on the forms was ensured by the specific 
qualifications of research staff. All patients were assigned a unique 
code during the first hospital visit, and forms were transmitted to 
the Munich depository without identification of the patient. Each 
patient form was checked for completeness and plausibility by 
members of the Munich Advisory Board. 
 Skin Prick Tests 
 In all patients, single skin testing was performed by medical 
doctors using prick lancets and commercially available extracts 
obtained from ALK-Abelló (Hørsholm, Denmark). The following 
allergen sources (sensitization groups in parentheses) were tested: 
ragweed extract ( A. artemisiifolia pollen),  Dermatophagoides 
pteronyssinus and  D. farinae (house dust mites) ,  cat and dog (an-
imal dander), grass mix and rye pollen (grass pollen), birch, alder, 
hazelnut, oak beech (tree pollen) and mugwort pollen. In addi-
tion, in patients from the Munich centre, skin prick tests with 
stinging nettle, ash, plantain and six molds ( Alternaria alternata , 
 Penicillium ,  Mucor ,  Rhizophus ,  Aspergillus  and Cladosporium ) 
could also be performed.
 Since potency and probably also composition may differ, each 
patient from the Munich centre underwent 4 additional tests for 
ragweed sensitization using ragweed extracts from four other 
manufacturers (Allergopharma, Reinbek, Germany; HAL Aller-
gy, Leiden, Netherlands; Allergy Therapeutics, Worthing, UK; 
Stallergenes, Antony Cedex, France). Histamine dihydrochloride 
10 mg/ml was used as a positive control, diluent as a negative con-
trol. The procedure adopted for skin testing followed recommen-
dations recently summarized by the Global Asthma and Allergy 
European Network (GA 2 LEN)  [13] . 
 For statistical analysis, sensitizations to allergens from differ-
ent animal hairs,  trees, house dust mites and from grass or rye 
were combined into 1 class each, yielding – together with mug-
wort and ragweed sensitization – a total of 6 sensitization groups. 
For testing positive for an allergen class, a patient had to be sensi-
tized to at least 1 allergen of this class. In patients from Munich, 
the additionally tested allergens (stinging nettle, ash, plantain and 
molds) increased the maximum number of sensitization groups 
to 10.
 Measurement of Ragweed-Specific IgE Concentration 
 Only patients from the Munich centre could be studied. A 
5-ml blood sample was taken at the first patient visit to determine 
the concentrations of ragweed-specific IgE antibodies. Measure-
ments were done by CAP-FEIA (ImmunoCAP 250, Phadia, 
Freiburg, Germany). After centrifugation, aliquots of 2 ml of se-
rum were frozen at –20 o C and stored until all samples were col-
lected, to allow a measurement by the same batch of test reagents. 
Results were given in kU/l. 
 Conjunctival Provocation Tests 
 Patients of the Munich centre who were found to be sensitized 
to ragweed, did not present with rhinoconjunctivitis and did not 
wear contact lenses, we performed a conjunctival provocation test 
according to a slightly modified method of Möller et al.  [14] . Three 
subjects without ragweed sensitization served as controls. We 
used a commercial preparation for the challenge test (HAL Al-
lergy) and made serial dilutions with the control solution (con-
taining 5% phenol) provided by the manufacturer to produce 4 
solutions at concentrations of 0.1, 1.0, 10 and 100% of the test so-
lution. We used the diluent as the negative control. We started by 
placing a single drop of the control solution into the right con-
junctival sac. We then placed single drops of successively stronger 
solutions in the left conjunctival sac at 20-min intervals, each step 
in the test sequence being contingent on a negative response in the 
immediately preceding test. We regarded any test as positive and 
concluded the procedure if, after inspection for redness and in-
quiry about eye itch, eye weeping, eye burning, nose dripping or 
nose blockage (score: mild = 1, moderate = 2 and severe = 3), a 
total score of 5 was reached.
 Outcome 
 The primary outcome of the study was a sensitization to rag-
weed. This was diagnosed if a patient had a positive skin reaction 
to ragweed after the ALK-Abelló allergen. For a separate analysis 
in a subgroup (patients from the Munich centre), ragweed sensi-
tization was also diagnosed if we had observed positive reactions 
to 2 extracts manufactured by a different company or if IgE mea-
surements revealed ragweed-specific IgE antibodies  1 0.35 kU/l. 
 Statistics 
 Multiple logistic regression was used to assess the statistical 
association of ragweed sensitization with several covariates of in-
terest. For categorical covariates, coefficients for all categories ex-
cept the reference category were included in the regression mod-
els. While these were estimated without constraints for nominal 
covariates with unordered categories, those of neighbouring cat-
egories were assumed to be similar for the ordinal covariates with 
ordered categories. The effects of continuous covariates and vary-
ing coefficients were modeled non-linearly  [15] . For the spatial 
county covariate it was assumed that neighbouring counties have 
similar coefficients.
 The models were estimated with Bayesian inference  [15] 
through the special software BayesX  [16] . Standard prior distribu-
tions were used for all model parameters. For linear effects, pos-
terior means as point estimates and posterior 95% credible inter-
vals were derived. In addition, simultaneous 95% credible bands 
were derived for non-linear effects. A relevant statistical associa-
tion was diagnosed when the reference odds ratio 1 was not in-
cluded in the 95% credible intervals, or when the posterior prob-
ability of a positive association with a covariate was  1 95 or  ! 5%, 
respectively.
 A baseline confounder model was selected by stepwise optimi-
zation of the deviance information criterion (DIC) by eliminating 
covariate terms or by simplifying non-linear terms to linear terms 
 [17] . In this model, mugwort sensitization was also part of the co-
variate ‘number of co-sensitization classes’. Like this, a specific 
mugwort association could be separated from the association re-
sulting from cross sensitization. To evaluate allergic airway dis-
eases, allergic asthma and allergic rhinoconjunctivitis were com-
bined into one single variable. To be classified as suffering from 
an allergic airway disease, a patient had to present either with al-
lergic asthma or allergic rhinoconjunctivitis, or both. The effect 
of this compound variable was modelled on the basis of a varying 
coefficient depending non-linearly on the duration of the disease. 
No attempts were made to evaluate different elicitors of food al-
lergy separately.
 To examine local geographical effects, we then tested 4 differ-
ent final models. In the first 2 models, we estimated an association 
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of the categorical covariate ‘county of residence’ or of the ordinal 
covariate ‘extent of county ragweed cover’ with ragweed sensiti-
zation. To evaluate the variable ‘extent of county ragweed cover’, 
classes 2 and 3, and 6 and 7 of that variable (see Methods) were 
combined into 2 classes, because only 1 patient was living in each 
of a class 2 or 7 county. The models contained an additional bi-
nary covariate adjusting for unobserved heterogeneity between 
the Munich centre and the regional centres. 
 Apart from 71 counties, the state of Bavaria includes 25 ‘coun-
ty-free’ cities. In the model, in which we estimated an association 
of the categorical covariate ‘county of residence’, patients living 
within Munich city-limits were used as the reference population 
(the city of Munich does not belong to a county). The remainder 
were analyzed according to the county or to county-free city they 
were living in. 
 The last 2 models were only estimated for patients of the Mu-
nich centre, for whom a more subtle analysis was possible. For 
these models, a separate construction was necessary because of 
differences in the definition of the covariate ‘number of aeroal-
lergens to which the patient was sensitized’ and because of the 
dependent variable ‘ragweed sensitization’. We either incorporat-
ed the variable ‘residential area’ or the variable ‘extent of county 
ragweed cover’ into the baseline confounder model to examine 
whether the local environment was of importance. In the model, 
in which we estimated an association of the categorical covariate 
‘residential area’, patients living within Munich city-limits were 
again used as the reference population. The remainder were ana-
lyzed according to whether they were living in Munich county 
(i.e. the suburban area surrounding Munich city-limits) or in the 
areas outside of it.
 Results 
 Clinical Characteristics of the Cohort 
 Originally, 1,272 subjects were enrolled in the study. In 
compliance with the exclusion criteria, a total of 977 pa-
tients were available for the evaluation of ragweed sensitiv-
ity and its predictive variables. The median patient age in 
the cohort was 43 years (interquartile range 30–56) and the 
majority of patients were female (62.0%). An atopic disease 
or food allergy could be diagnosed in 63.9% of the patients. 
Among the 977 patients, 49.6% were suffering from allergic 
asthma or rhinoconjunctivitis, 25.9% presented with atop-
ic eczema and 29.0% had a food allergy (tree nuts 16.8%, 
pip and/or stone fruits 15.4%, celery 3.6%, fish and/or sea-
food 2.1%, milk 1.0%, hen’s egg 0.6% and rye and/or wheat 
0.2%). Most patients had an allergy to various elicitors, and 
only 11 patients (1.1%) were suffering from an exclusive 
non-vegetable food-induced allergic disorder (milk, fish 
and/or seafood or hen’s egg allergy). Among these 11 pa-
tients, however, 9 simultaneously presented with positive 
skin prick test reactions to cross-reacting allergens (e.g. an 
allergy to house dust mite in seafood-allergic patients). 
 The majority of the patient cohort (60.4%) was sensi-
tized to one or more aeroallergens. In 23.4% of the pa-
tients, a sensitization to mugwort could be identified, and 
according to skin prick test results 19.5% of the patients 
were sensitized to ragweed. Larger numbers of sensitiza-
tions appeared to be less common than sensitization to 
only one aeroallergen ( fig. 1 ). There was a strong correla-
tion between the number of co-sensitizations and the 
corresponding frequency of ragweed sensitization. We 
performed conjunctival provocation tests in 48 patients 
who were sensitized to ragweed. Twenty-six (54.2%) were 
tested positive for ragweed. Three controls did not react 
to the conjunctival challenge test. 
 Independent Predictors of Ragweed Sensitization  
 Ragweed sensitization was significantly more com-
mon in male patients, in  patients whose complaints oc-
curred chiefly during September and October, in those 
who experienced symptoms during only a few months of 
the year and in those who were suffering from food al-
lergy ( table 1 ). A stronger predictor for ragweed sensitiza-
tion was a sensitization to mugwort. The strongest asso-
ciation, however, could be identified for the number of 
co-sensitization classes with odds ratios ranking between 
7 and 70 ( fig. 2 ). The variables ‘atopic eczema’ and ‘time 
between appearance of first symptoms and office visit’ 
were retained in the final model, but were not relevant. 
Similarly, the variable ‘extent of county ragweed cover’ 
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 Fig. 1. Frequency distribution of polysensitization to 6 groups of 
aeroallergens (house dust mites, animal dander and pollen from 
grasses, trees, mugwort and  A. artemisiifolia ) in patients with 
documented or presumed atopy and/or food allergy (n = 977). 
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did not gain relevance. Several other variables (‘age’, ‘his-
tory of residential changes’, ‘need for an anti-allergic 
medication’, ‘allergic upper airway disease’, ‘complaints 
during summertime’ or ‘month in which symptoms had 
been experienced’) were not included in the final model, 
emphasizing that these covariates were unimportant.
 We also constructed a second model, in which we re-
placed the variable ‘extent of county ragweed cover’ by 
the variable ‘county of residence’. The corresponding re-
sults of the final model were qualitatively and also quan-
titatively almost identical to the first model. A relevant 
association with a specific county could not be identified. 
Posterior probabilities of a positive association with rag-
weed sensitization risk varied between 28 and 41% ( fig. 3 ). 
According to the statistical methods used, a significant 
association between the dependent and an independent 
variable can only be assumed, if corresponding posterior 
probabilities are  ! 5 or  1 95%.
 Independent Predictors for a Ragweed Sensitization in 
Patients from the Munich Centre 
 In the Munich centre (n = 873), a more subtle analysis 
of co-sensitizations and an extended diagnosis of rag-
weed sensitization had been possible, justifying a sepa-
rate analysis. In that model, we specifically tested the rel-
evance of the categorical variable ‘residential area’. The 
final multivariate model ( table 2 ) yielded results which 
were almost identical to those obtained for the whole
cohort. Again, we found an extraordinarily strong asso-
ciation between ragweed sensitization and the extent of 
polysensitization. The risk of being sensitized to ragweed 
steadily and significantly increased with the number of 
additional positive reactions to other common aeroaller-
gens ( fig. 4 ). On the other hand, variables reflecting resi-
dential areas (suburban, rural) were part of the final 
model, but did not gain sufficient relevance when com-
pared to the reference category (urban residence). In that 
model, we also retested the importance of the variable 
‘extent of county ragweed cover’ for ragweed sensitiza-
tion (by replacing the variable ‘residential area’). As for 
the whole cohort, no relevant associations could be found, 
and all other predictors were also virtually identical. 
Table 1.  Results of the final Bayesian model for the probability to be sensitized to ragweed (n = 977)
Variable Odds ratio 9 5% credible interval Posterior probability for a 
positive association (%)
Atopic eczema 1.1171 0.6564 1.6441 64.4
Female gender 0.6856 0.4045 0.9977 3.6
Food allergy 1.9777 1.1507 2.9393 99.6
Mugwort sensitization 5.0197 2.5362 7.7213 100.0
Maximum symptoms in September/October 4.0333 1.3552 7.4813 100.0
Duration of symptoms within 1 year (months) 0.8712 0.7686 0.9722 0.9
Regional centre 0.5148 0.1117 1.0149 5.0
Number of co-sensitization groups n.a. (ordinal variable, fig. 2)
 n.a. (ordinal variable)Extent of county ragweed cover
Dat a were adjusted to the effect of the extent of county ragweed cover. Variables selected according to the DIC are shown. A relevant 
association can be assumed when the posterior probability for a positive association with a covariate is >95 or <5%, respectively. 
n.a. = Not applicable.
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 Fig. 2. Covariate-adjusted association between the number of co-
sensitization groups (except ragweed) and the risk of becoming 
sensitized to ragweed (n = 977). Odds ratio refers to subjects not 
sensitized to any aeroallergen.  
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 Discussion 
 Our study is the first to evaluate the importance of a 
variety of suspected clinical, environmental and geo-
graphical risk factors for acquiring a ragweed sensitiza-
tion in a high-risk population. This population comprised 
adult patients with a suspected or documented allergic 
upper airway disease, atopic eczema, or food allergy. 
 In our largely south Bavarian cohort, about 20% of the 
patients tested positive for ragweed. According to a recent 
European epidemiological study, the average pan-Euro-
pean frequency of ragweed sensitization in high-risk pa-
tients was 14.1%. Similar rates were found in patients 
from 3 German allergy centres  [13] , but variations be-
tween different European countries were extremely high 
(2–54%). 
 The high frequency of ragweed sensitization presum-
ably results from 2 different phenomena. Firstly, it is pos-
sible that a portion of patients sensitized to ragweed ac-
quired this sensitization via cross-reactivity to mugwort. 
This hypothesis is supported by our finding that mug-
wort sensitization was the second strongest, independent 
predictor for a ragweed sensitization (topped only by the 
extent of polysensitization) ( tables 1 and  2 : corresponding 
odds ratios). Primary ragweed sensitization is, however, 
a more likely explanation for our findings because re-
gional allergen exposure increased throughout the last 
two decades. Long-term observation data from Vienna, 
Austria showed that, among patients with inhalative al-
lergic diseases, the frequency of ragweed-specific IgE an-
tibodies had risen from 20% in the late 1980s to about 
30% at the end of the 1990s  [9] . These findings correlate 
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 Fig. 3. Covariate-adjusted association between county of resi-
dence (Bavaria) and the risk of becoming sensitized to ragweed 
(n = 977). Numbering of the gray scale indicate posterior proba-
bilities for a positive association with ragweed sensitization risk. 
Reference category for the risk of becoming sensitized to ragweed 
is the area defined by Munich city-limits (arrow). The lowest pos-
terior probability (as indicated by the darkest gray) was identified 
for Miesbach county (0.28). A significant positive association be-
tween ragweed sensitization and county of residence can only be 
assumed, if corresponding posterior probabilities are  ! 0.05. (I = 
City of Nuremberg, II = city of Munich). 
 Common Ragweed in Bavaria   Int Arch Allergy Immunol 2012;159:65–74 71
well with a 3-times-elevated annual ragweed pollen load 
over the same period of time. Correspondingly, ragweed 
pollen allergy is also quite a recent phenomenon. In 
northern Italy, the presence of ragweed had been report-
ed in the area of Turin since the beginning of the 1980s; 
however, it was only at the end of that decade that rag-
weed allergy began its dramatic increase, starting in the 
surroundings of Milan  [4] . Ragweed sensitization may 
also be relevant from a clinical point of view. This is evi-
dent from the preliminary results of our study concern-
ing the frequency of ragweed allergy in patients sensi-
tized to ragweed. Among the patients on whom we could 
also perform a conjunctival provocation test, 54.2% test-
ed positive for ragweed.
 In our study, the most important determinant for a 
ragweed sensitization was the number of sensitizations 
towards other aeroallergen groups (polysensitization). 
Polysensitization is a distinct phenomenon in atopic dis-
eases, as it is associated with an increased severity of or 
likelihood for allergic diseases  [18–21] and with a familial 
coincidence suggesting a genetic basis  [22, 23] . According 
to our results, polysensitization may also indicate a high 
susceptibility on the level of induction of an inhalant al-
lergy. After adjusting to numerous confounders (such as 
sensitization to mugwort, sex, age, place of residence, en-
vironment or the presence of atopic diseases), it was found 
that with the number of sensitizations to other aeroaller-
gen groups increasing the likelihood of being sensitized 
to ragweed also increased significantly. This finding is in 
line with observations by several other descriptive studies 
showing a similar association for other aeroallergens  [20, 
24, 25] . The latter longitudinal studies, however, did not 
adjust the polysensitization effect to other confounders. 
 According to our multivariate analyses, we can be rea-
sonably certain that this polysensitization effect is inde-
pendent of other covariables and represents an entity of 
its own. It appears that patients with multiple sensitiza-
Table 2.  Results of the final Bayesian model for the probability to be sensitized to ragweed
Variable Odds
ratio
95% credible interval Posterior probability for a 
positive association (%)
Atopic eczema 1.1419 0.6485 1.6543 67.8
Female gender 0.6891 0.4173 0.9961 3.4
Food allergy 1.6792 0.9577 2.4582 98.3
Mugwort sensitization 4.6879 2.5960 7.2685 100.0
Maximum symptoms in September/October 2.3241 0.7806 4.4014 96.4
Duration of symptoms within one year (months) 0.9014 0.7918 1.0048 3.9
Residential area: suburban 0.9023 0.2910 1.6183 32.8
Residential area: rural 1.3512 0.7887 1.9549 89.1
Time between appearance of first symptoms and office visit (years) n.a. (smoothed model)
Number of co-sensitization groups  n.a. (ordinal variable, fig. 4)
O nly data from the Munich centre were analyzed (n = 873). Data were adjusted to the effect of the residential areas. Urban place of 
residence was the reference category. Variables selected according to the DIC are shown. A relevant association can be assumed when 
the posterior probability for a positive association with a covariate is >95 or <5%, respectively. n.a. = Not applicable.
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 Fig. 4. Covariate-adjusted association between the number of co-
sensitization groups (except ragweed) and the risk of becoming 
sensitized to ragweed. Nine groups of aeroallergens were tested 
(house dust mites, animal dander, molds and pollen from grasses, 
trees, mugwort, stinging nettle, ash and plantain). Data exclu-
sively refer to patients from the Munich centre, in whom an ex-
tended diagnosis was possible (n = 873). Odds ratio refers to sub-
jects not sensitized to any aeroallergen. 
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tions are more readily sensitized to a new aeroallergen. 
This hypothesis may be compared to experimental and 
clinical findings in other types of allergy (contact aller-
gy), where there is sufficient evidence that polysensitiza-
tion is a clinical sign of increased susceptibility towards 
new allergens  [26] . 
 Our findings also add further quantitative elements to 
the notion of sensitization to an inhalant allergy as being 
a graded phenomenon, depending not only on exposure 
dose and allergen potency, but also on graded susceptibil-
ity  [27] . The molecular basis of this heightened suscepti-
bility consists in the phenomenon of Th 2 collateral prim-
ing indicating a process, in which Th 2 cells specific for 
one inhaled antigen can facilitate the priming of naive T 
cells to unrelated new inhaled allergens, and which is as-
sociated with an increase in IL-4 production from pe-
ripheral blood mononuclear cells (PBMC)  [28] . IL-4 pro-
duction by in vitro-activated PBMC is significantly high-
er in polysensitized than in monosensitized patients, 
showing that PBMC of mono- and polysensitized subjects 
have a different IL-4 profile  [29] . 
 Several of our other findings deserve specific com-
ment. It is generally believed that people who live in ur-
ban areas tend to be more affected by pollen-induced re-
spiratory allergy than people living in rural areas  [4] . 
Furthermore, components of air pollution may enhance 
the risk of both atopic sensitization and the exacerbation 
of symptoms in sensitized subjects  [4] . On the other hand, 
it was shown that the ragweed pollen count is lower in 
cities that in a rural environment  [30] .
 We found that neither the residential area (urban, sub-
urban or rural), nor the county of residence, residential 
history or the extent of county ragweed cover were sig-
nificantly associated with ragweed sensitization. These 
findings seem to be in contrast with the results of a recent 
observational study from Canada, where it was found 
that ragweed sensitization was lower in the predominant-
ly rural areas than in urban Canadian cities  [31] . There 
may be various methodological reasons for the differenc-
es between this particular study and our findings; it ex-
amined healthy adults, whereas we included only patients 
with suspected or documented atopic diseases. Further-
more, the Canadian study did not make adjustments for 
the most important confounders for ragweed sensitiza-
tion, namely mugwort sensitization and the total number 
of other allergen groups to which subjects might have 
been simultaneously sensitized. 
 According to our results, it appears that residential, 
local geographical or environmental conditions are of 
minor importance for becoming sensitized to ragweed. 
The explanation for the relative unimportance of these 
local variables can most likely be found in the biology and 
physical characteristics of ragweed pollen. Ragweed 
plants produce an enormous amount of pollen, which 
easily disperses over hundreds of kilometers  [4] . In cen-
tral Italy, several episodes of detection of ragweed pollen 
appeared to be linked to air masses coming from the Bal-
kan states (possibly Hungary). Correspondingly, in con-
trast to other aeroallergens, neither the type of residential 
area nor the local weather conditions were found to cor-
relate with daily ragweed pollen concentrations or aver-
age pollen index  [30, 32] . Since very little ragweed antigen 
is necessary to become sensitized, there is an increasing 
trend towards ragweed allergy in neighbouring regions 
where plants are not present  [4] . Consequently, it appears 
plausible that local geographical confounders are com-
paratively unimportant for ragweed sensitization. Our 
results support the notion that ragweed pollen spreads 
universally, and that its dispersion is much less controlled 
by local environmental or geographical conditions than 
that of other aeroallergens.
 Finally, we could confirm established covariates pre-
dicting a pollen sensitization (gender and food allergy), 
or a ragweed-specific sensitization (most complaints oc-
curring in September or October) in a high-risk cohort. 
On the other hand, in our patients, who were all older 
than 18 years, age did not correlate with the frequency of 
ragweed sensitization. This finding is surprising because 
several other cross-sectional studies demonstrated a de-
creasing frequency of aeroallergen sensitization with 
greater age  [20, 33] . This age-related immunological def-
icit does not appear to materialize after ragweed expo-
sure. This observation may highlight the extraordinarily 
strong allergenic capacity of this antigen which affects 
old and young high-risk patients to the same extent. A 
similar phenomenon has also been observed in the north-
ern Italian population, in which the de novo exposure to 
ragweed resulted in the unexpected sensitization of many 
older people  [34] .
 The extraordinary allergenic characteristics of rag-
weed pollen coincide with the dissemination of  A. arte-
misiifolia plants throughout central Europe including 
southern Bavaria. To avoid or limit the formation of new 
ragweed seeds and the further spread of the ragweed in-
festation, 3 different anti-ragweed measures and preven-
tion strategies have been proposed. The first concept, 
which has also been recommended by the World Health 
Organization concerning the future of allergies  [35] , 
propagates the eradication of ragweed. As long-distance 
travel of ragweed pollen is now widely acknowledged, 
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eradication programs limited to particular countries will 
not succeed and a pan-European action would be needed 
 [36] . Secondly, it may be helpful to treat other inhalant 
allergies as aggressively as possible to prevent a future 
ragweed sensitization/allergy via priming mechanisms. 
This concept is, however, still hypothetical, because the 
majority of studies (all retrospective in nature) could not 
demonstrate such a preventive effect  [37–40] . Finally, to 
prevent ragweed-induced symptoms, it has been pro-
posed that informing and educating risk patients would 
enable them to practice a strategy of allergen avoidance 
behaviour  [41] . Specific preventive measures should be 
offered to high-risk patients with multiple sensitizations 
who are more readily sensitized to a new, highly aller-
genic aeroallergen.
 Study Limitations 
 The results of our study may not be generalizable be-
cause they represent the experience of a single centre and 
reflect a unique case mix, organization and process of 
care. Due to the retrospective nature of the study, the re-
sults must be interpreted with care and may only be re-
garded as material to generate hypotheses. Furthermore, 
we were unable to collect patient-specific data for rag-
weed allergen exposure during the recruitment period of 
the study (2006–2009). In Bavaria at that time, only the 
regional extent of ragweed cover was available as a sur-
rogate variable for ragweed allergen exposure. However, 
studies have shown a reasonable correlation between the 
extent of local ragweed cover and ragweed allergen expo-
sure  [42] . In addition, the precise allergen concentration 
in commercially available standard extracts used for con-
junctival provocation tests is not known. Therefore, re-
sults of corresponding tests might potentially have been 
obscured by allergen concentrations either too low to 
produce specific symptoms, or too high, thereby possibly 
producing unspecific symptoms. Finally, according to a 
decision of the Institutional Review Board, it was not per-
mitted to include children or adolescents in this pilot 
study; they might have shown a different predisposition 
to become sensitized to ragweed.
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